Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

N/ACompletedNCT02073981

Kyowa Kirin Co., Ltd.1,021 enrolled

Overview

This study is implemented to identify factors having an impact on improvement or exacerbation of non-motor symptoms, to provide information contributing to development of medical care in this field and improvement of patients' QOL, and to clarify the association between the use of istradefylline and non-motor symptoms or QOL.

Study Type

OBSERVATIONAL

Enrollment

1,021

Conditions

Parkinson Disease

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who have wearing off under treatment with levodopa-containing drugs administered at least three times daily * Patients who have at least one non-motor symptom as a complication * Patients at least 20 years of age at the time of consent * Patients who have given written consent * Patients who are receiving outpatient care Exclusion Criteria: * Patients with dementia or a score of 23 or less on the Mini-Mental State Examination (MMSE) * Patients, in the opinion of the investigator or subinvestigator, having conditions impairing the proper assessment of the MDS-UPDRS or PDQ-8 (e.g., patients who are receiving treatment for malignant tumor)

Locations (1)

Juntendo University Hospital

Bunkyo-ku, Tokyo, Japan

Outcomes

Primary Outcomes

Changing of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

MDS-UPDRS score will be collected from all registrant at each visit and on the last day of survey.

Time frame: 52 weeks

Changing of Parkinson's Disease Questionaire-8 (PDQ-8) score.

PDQ-8 score will be collected from all registrant at each visit and on the last day of survey.

Time frame: 52 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.